Drug Shortage Report for HYPERTET S/D
Report ID | 139131 |
Drug Identification Number | 02230697 |
Brand name | HYPERTET S/D |
Common or Proper name | TETANUS IMMUNOGLOBULIN (HUMAN), SOLVENT DETERGENT TREATED |
Company Name | GRIFOLS THERAPEUTICS LLC |
Market Status | DORMANT |
Active Ingredient(s) | TETANUS IMMUNOGLOBULIN |
Strength(s) | 250UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 250 IU Syringe |
ATC code | J06BB |
ATC description | IMMUNOGLOBULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-05-11 |
Actual start date | |
Estimated end date | 2021-05-12 |
Actual end date | 2021-05-11 |
Shortage status | Resolved |
Updated date | 2021-05-12 |
Company comments | To ensure continuous supply while Grifols implements a planned manufacturing process update for this product, Grifols has received authorization from Health Canada to distribute HyperTET® S/D Lot No. T2MDE00023 that has a US label on its pre-filled syringe. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | GrifolsCanadaMedInfo@grifols.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-05-12 | English | Compare |
v13 | 2021-05-11 | French | Compare |
v12 | 2021-05-11 | English | Compare |
v11 | 2021-05-11 | English | Compare |
v10 | 2021-05-10 | French | Compare |
v9 | 2021-05-10 | French | Compare |
v8 | 2021-05-10 | English | Compare |
v7 | 2021-05-10 | French | Compare |
v6 | 2021-05-10 | English | Compare |
v5 | 2021-05-10 | French | Compare |
v4 | 2021-05-10 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v2 | 2021-05-10 | English | Compare |
v1 | 2021-05-10 | English | Compare |
Showing 1 to 14 of 14